Example: Heart Attack
Clinical Trials Sponsored by Prostate Cancer Foundation Clinical Research Consortium
Total 2 results
-
NCT01961713RecruitingConditions: Prostate Cancer
-
NCT00953576TerminatedConditions: Prostate Cancer
Cookie Settings
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes below. Please carefully read our Terms of Service before you proceed with using any part of this website.
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
Sponsors and Collaborators
- Centre Hospitalier Universitaire Brugmann
- Clinique Saint-Jean, Bruxelles
- Effice Servicios Para la Investigacion S.L.
- Ehime University Graduate School of Medicine
- Hospital Universitario La Fe
- Indiana University School of Medicine
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- National Institute of Cancerologia
- Oclassen Pharmaceuticals
- St. Marianna University School of Medicine
- Swedish Match AB
- University Hospital, Essen
- VGX Pharmaceuticals, LLC
- View Full List
Drug Interventions
- Amodiaquine, artesunate drug combination
- Antineoplastic Agents, Alkylating
- Antisickling Agents
- Cefpodoxime
- Dasatinib
- Dimethyl Sulfoxide
- Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
- Ganciclovir
- Moclobemide
- Muscle Relaxants, Central
- N-Methyl-3,4-methylenedioxyamphetamine
- Ropinirole
- Wobenzym
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations